# Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?

> **NCT01997762** · PHASE4 · UNKNOWN · sponsor: **University of Manitoba** · enrollment: 112 (estimated)

## Conditions studied

- Gestational Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Resveratrol
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01997762
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2014-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01997762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01997762, "Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01997762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*